Female Hypoactive Sexual Desire Disorder Therapeutics Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281448 No. of Pages: 65 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Female Hypoactive Sexual Desire Disorder Therapeutics in Global, including the following market information:
Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Female Hypoactive Sexual Desire Disorder Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
BP-101 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Female Hypoactive Sexual Desire Disorder Therapeutics include Emotional Brain BV, GlaxoSmithKline Plc, Palatin Technologies Inc, Pivot Pharmaceuticals Inc and Strategic Science & Technologies LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Female Hypoactive Sexual Desire Disorder Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Female Hypoactive Sexual Desire Disorder Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Segment Percentages, by Type, 2021 (%)
BP-101
Bremelanotide
Gepirone Hydrochloride ER
PVT-011
Others
Global Female Hypoactive Sexual Desire Disorder Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Segment Percentages, by Application, 2021 (%)
Out-Patient
In-Patient
Global Female Hypoactive Sexual Desire Disorder Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Female Hypoactive Sexual Desire Disorder Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Female Hypoactive Sexual Desire Disorder Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Emotional Brain BV
GlaxoSmithKline Plc
Palatin Technologies Inc
Pivot Pharmaceuticals Inc
Strategic Science & Technologies LLC
1 Introduction to Research & Analysis Reports
1.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Overall Market Size
2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size: 2021 VS 2028
2.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Female Hypoactive Sexual Desire Disorder Therapeutics Players in Global Market
3.2 Top Global Female Hypoactive Sexual Desire Disorder Therapeutics Companies Ranked by Revenue
3.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Female Hypoactive Sexual Desire Disorder Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Female Hypoactive Sexual Desire Disorder Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Female Hypoactive Sexual Desire Disorder Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Female Hypoactive Sexual Desire Disorder Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Female Hypoactive Sexual Desire Disorder Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Markets, 2021 & 2028
4.1.2 BP-101
4.1.3 Bremelanotide
4.1.4 Gepirone Hydrochloride ER
4.1.5 PVT-011
4.1.6 Others
4.2 By Type - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2021 & 2028
5.1.2 Out-Patient
5.1.3 In-Patient
5.2 By Application - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2017-2028
6.3.2 US Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.3.3 Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.3.4 Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2017-2028
6.4.2 Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.4.3 France Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.4.4 U.K. Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.4.5 Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.4.6 Russia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.4.8 Benelux Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2017-2028
6.5.2 China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.5.3 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.5.4 South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.5.6 India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2017-2028
6.6.2 Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.6.3 Argentina Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, 2017-2028
6.7.2 Turkey Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.7.3 Israel Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
6.7.5 UAE Female Hypoactive Sexual Desire Disorder Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Emotional Brain BV
7.1.1 Emotional Brain BV Corporate Summary
7.1.2 Emotional Brain BV Business Overview
7.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Major Product Offerings
7.1.4 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Emotional Brain BV Key News
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Corporate Summary
7.2.2 GlaxoSmithKline Plc Business Overview
7.2.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Major Product Offerings
7.2.4 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline Plc Key News
7.3 Palatin Technologies Inc
7.3.1 Palatin Technologies Inc Corporate Summary
7.3.2 Palatin Technologies Inc Business Overview
7.3.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Major Product Offerings
7.3.4 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Palatin Technologies Inc Key News
7.4 Pivot Pharmaceuticals Inc
7.4.1 Pivot Pharmaceuticals Inc Corporate Summary
7.4.2 Pivot Pharmaceuticals Inc Business Overview
7.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Major Product Offerings
7.4.4 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Pivot Pharmaceuticals Inc Key News
7.5 Strategic Science & Technologies LLC
7.5.1 Strategic Science & Technologies LLC Corporate Summary
7.5.2 Strategic Science & Technologies LLC Business Overview
7.5.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Major Product Offerings
7.5.4 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Strategic Science & Technologies LLC Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com